Archives: Agenda

Accelerate, cultivate, innovate!

• Managing relationships with the modern supplier
• How Bayer’s external relationship governance model adds value to the business ensuring a reliable partnership and complements the sourcing & procurement functions within CTS scope
• Trends on procurement roles and the necessity to have an operational perspective
• Different approaches from different business necessities
• Trends on how to best manage CMOs, 3PLs and clinical trials partners

Consistent patient engagement is vital to clinical trial success, yet dropout and non-compliance remain persistent challenges. This session introduces gamification as a scientifically grounded strategy to boost retention, enhance adherence, and streamline trial execution.

• Understand the Science: Explore the behavioral and psychological foundations that make gamification a powerful tool for sustaining patient motivation
• See Real Results: Review real-world case studies where gamification significantly improved retention, compliance, and trial timelines
• Apply Proven Methods: Learn practical strategies and best practices for integrating gamified elements into clinical trial protocols

In recent years, some of the most damaging cyberattacks in Europe share a common thread – identity. As traditional defences strengthen, attackers have shifted tactics, moving away from malware and exploits toward abusing legitimate credentials, permissions, and trust relationships within enterprise environments.

This session considers how attackers use identities to navigate industry-standard defences. We’ll explore the anatomy of an identity-based attack – from initial access through to organisational-wide takeover – and highlight recurring patterns seen across European enterprises.

Today’s breaches aren’t the result of poor security but of unseen complexity. Hidden identity attack paths buried deep in Active Directory and Entra ID provide adversaries with millions of routes to critical systems.

We’ll conclude with a strategy to move from reactive defence to proactive identity risk management. By continuously mapping and removing identity attack paths, organisations can eliminate the bridges adversaries depend on.

• Enhancing real-time data visibility and accuracy
• Streamlining compliance and regulatory adherence
• Boosting flexibility and efficiency in clinical supply management

• Highlighting the key changes in ICH E6 (R3) and their practical implications for clinical trial conduct
• Exploring approaches to implementing new guidelines in diverse trial settings
• Analysing challenges, opportunities, and interpretations associated with ICH E6 (R3)
• Sharing actions taken so far to comply with latest updates